
Prosomnus Investor Relations Material
Latest events

Q4 2023
Prosomnus
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Prosomnus Inc
Access all reports
ProSomnus Inc is a medical technology company specializing in the development, manufacturing, and marketing of precision intraoral medical devices. These devices are designed to treat and manage obstructive sleep apnea (OSA), a condition that affects a significant portion of the global population. The company's innovative approach involves creating customized oral appliance therapy devices, offering a non-CPAP alternative for OSA treatment. ProSomnus sells its products through a direct sales force to a variety of healthcare providers, including sleep dentists, sleep physicians, primary care providers, and otolaryngologists, aiming to provide an effective solution for the management of sleep apnea. The company is headquartered in Pleasanton, California, and its shares are listed on the Nasdaq.
Latest articles
)
Airbnb: The Hospitality Giant Without Property
Airbnb has grown from an idea to help the Co-Founders make rent, to one of the most dominant companies in the global hospitality industry.
13 Jun 2025
)
MSCI: Indexing the World
The story of how MSCI has become the backbone of global finance through its indexes, powering decision-making across trillions in assets.
30 May 2025
)
A Purpose-Built AI Chat for Finance and IR Professionals
Quartr Pro's new AI chat lets IR and finance professionals ask anything across 13,000+ public companies and get instant answers.
27 May 2025
Ticker symbol
OSA
Country
🇺🇸 United States